Related Experiment Video
Updated: Aug 14, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
[Cardiogenic shock in acute myocardial infarction--what we know in 2005]
Insights
Cardiogenic shock, a severe complication of heart attack, has high mortality rates. Current treatments focus on medications, mechanical support, and interventions to improve patient outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
Context:
- Cardiogenic shock complicates up to 10% of acute myocardial infarction cases.
- High mortality rates persist despite advancements in acute myocardial infarction management.
Purpose:
- To review contemporary treatment strategies for cardiogenic shock.
- To highlight the role of novel therapeutic agents and mechanical circulatory support.
Summary:
- Investigational treatments include inhibitors of nitric oxide synthase alongside established medications.
- Mechanical circulatory support devices such as intra-aortic balloon pumps and left ventricular assist devices are crucial.
- Percutaneous coronary intervention is a key factor in improving prognosis.
Impact:
- Improved understanding of multifaceted treatment approaches for cardiogenic shock.
- Potential for enhanced patient survival rates in acute myocardial infarction complicated by shock.
Abstract:
Cardiogenic shock represents a complication in up to 10% of patients with acute myocardial infarction. Cardiogenic shock mortality remains high. In the contemporary treatment inhibitors of NO synthase are studied, apart from classic medications. Mechanical circulatory support is also important in majority of patients with cardiogenic shock: intraaortic balloon contrapulsation, left ventricular assist device systems. Prognosis is improved by percutaneous coronary intervention.
Related Concept Videos
Introduction Cardiac Emergencies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

